Are you Dr. Civin?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 N Wolfe St
Baltimore, MD 21287Phone+1 410-955-8751
Summary
- Dr. Curt Civin, MD is an oncologist in Baltimore, Maryland. He is currently licensed to practice medicine in Maryland. He is a Professor at University of Maryland School of Medicine.
Education & Training
Harvard Medical SchoolClass of 1974
Certifications & Licensure
MD State Medical License 1976 - 2022
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- The polypharmacy combination of the BCL-2 inhibitor venetoclax (VEN) and the FLT3 inhibitor gilteritinib (GIL) is more active in acute myeloid leukemia cells than nove...Christopher C Goodis, Christian Eberly, Alexandria M Chan, MinJung Kim, Brandon D Lowe
European Journal of Medicinal Chemistry. 2025-03-05 - ART714 is a best-in-class antileukemic 2-carbon-linked dimeric artemisinin derivative.Amanda B Kagan, Blake S Moses, Rena Lapidus, Bryan T Mott, Ganesha Rai
Cancer Chemotherapy and Pharmacology. 2023-07-01 - 4 citationsComparative efficacy and mechanism of action of cardiac progenitor cells after cardiac injury.Muthukumar Gunasekaran, Rachana Mishra, Progyaparamita Saha, David Morales, Wen-Chih Cheng
Iscience. 2022-08-19
Press Mentions
Academic Labs Are Opening Back up. Still, Research Isn’t Exactly Back to NormalJuly 20th, 2020- CITI Program, in Collaboration with Consortium, Launches Free Online Course “COVID-19: Back to Campus”June 16th, 2020
New Anti-IL-7Rα Monoclonal Antibodies Show Efficacy Against T Cell Acute Lymphoblastic Leukemia in Pre-Clinical ModelsAugust 22nd, 2019- Join now to see all
